Health Plans Sue Abbott Over Depakote Off-Label Scheme

Law360, New York (August 16, 2013, 5:21 PM EDT) -- Abbott Laboratories Inc. was hit with a proposed class action in Illinois federal court Friday by three health benefit plans alleging it unfairly reaped hundreds of millions of dollars from third-party payors through off-label marketing and kickbacks for prescriptions of anti-seizure medication Depakote.

According to the plaintiffs — Sidney Hillman Health Center of Rochester, Teamsters Health Services and Insurance Plan Local 404 and United Food and Commercial Workers Unions and Employers Midwest Health Benefits Fund — Abbott's misbranding scheme had resulted in private payors reimbursing many...
To view the full article, register now.